Nanjing, China

Chenggang Lin

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chenggang Lin: Innovator in Pharmaceutical Chemistry

Introduction

Chenggang Lin is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of donepezil derivatives. With a total of 2 patents, his work focuses on innovative solutions for treating diseases related to acetylcholinesterase activity.

Latest Patents

Chenggang Lin's latest patents include a donepezil derivative and its use in medicinal applications. The invention relates to a donepezil derivative of general formula (I) or a pharmaceutically acceptable salt thereof. The patent outlines a method for preparation and a composition comprising an effective amount of the compound. Furthermore, it discusses the use of this compound in preparing a medicament for treating diseases resulting from abnormalities in acetylcholinesterase activity.

Career Highlights

Throughout his career, Chenggang Lin has worked with reputable companies such as Noratech Pharmaceuticals, Inc. and Nanjing Noratech Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Chenggang Lin has collaborated with several professionals in his field, including Fei Liu and Cuixia Zhang. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Chenggang Lin is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach and dedication to research continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…